Hormone Therapy for Postmenopausal Women
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Hormone therapy is highly effective for the management of vasomotor symptoms in postmenopausal women; vaginal estrogen is used for genitourinary symptoms only. Hormone therapy is not recommended for primary or secondary prevention of coronary heart disease or dementia. Several nonhormonal therapies are also effective for vasomotor symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This could be due to the first-pass through the liver with oral MHT, enabling increased triglycerides, coagulation factors, and C-reactive protein, which is minimized with transdermal therapy (211, 212).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [211]
Citations
Cites
1 retracted
RETRACTED: Practice Bulletin No. 141 Management of Menopausal Symptoms
(2014) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000441353.20693.78 · Cited by 434
RetractedWriting Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition
Avis, N. E., Crawford, S. L., Greendale, G., Bromberger, J. T., Everson-Rose, S. A., Gold, E. B., Hess, R., Joffe, H., Kravitz, H. M., Tepper, P. G., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8063 · Cited by 1,028
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Self-citation
Research works printed but not linked: 2
- Espeland MA, Rapp SR, Manson JE, et al. Long-term effects on cognitive trajectories of postmenopausal hormone therapy in two age groups. J Gerontol A Biol Sci Med Sci 2017;72:838-845.27506836
- Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2009;4:CD001405-CD001405.19821277
Cited by
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
McCarthy, M., & Raval, A. P. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01998-9 · Cited by 254
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N., Shifren, J. L., Shufelt, C. L., Stuenkel, C. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061559 · Cited by 205
Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts
Mehta, J., Kling, J. M., & Manson, J. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.564781 · Cited by 186
Estrogens in adipose tissue physiology and obesity-related dysfunction
Kuryłowicz, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030690 · Cited by 178
Metadata
- Authors
- Pinkerton, J. V.
- Affiliations
- University of Virginia Health System (US)
- Corresponding author
- Pinkerton, JoAnn V.
- ORCID
- Pinkerton, JoAnn V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-01-30
- Volume
- 382
- Issue
- 5
- Pages
- 446-455
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3003579746
- Cited by
- 220
- References
- 50
- Citations by year
- 2026: 32 · 2025: 33 · 2024: 32 · 2023: 26 · 2022: 43 · 2021: 30 · 2020: 24
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- hormone therapy, postmenopausal women, vasomotor symptoms, menopause, vaginal estrogen, genitourinary symptoms, coronary heart disease prevention, dementia prevention, non-hormonal therapy
- MeSH terms
- Administration, Intravaginal, Age Factors, Breast Neoplasms, Cardiovascular Diseases, Female, Humans, Middle Aged, Sweating, Estrogen Replacement Therapy, Selective Serotonin Reuptake Inhibitors, Practice Guidelines as Topic, Postmenopause, Hot Flashes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormone Therapy for Postmenopausal Women. https://app.cochat.ai/papers/10.1056/nejmcp1714787
- The paper
- Pinkerton, J. V. (2020). Hormone Therapy for Postmenopausal Women. New England Journal of Medicine. https://doi.org/10.1056/nejmcp1714787
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.